Severe acute thrombotic exacerbation in two cases with anti-phospholipid syndrome after retreatment with rituximab in phase I/II clinical trial for refractory systemic lupus erythematosus

MeSH terms

• Acute Disease
• Adult
• Antibodies, Monoclonal / adverse effects*
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Murine-Derived
• Antiphospholipid Syndrome / drug therapy*
• Female
• Humans
• Immunologic Factors / adverse effects*
• Immunologic Factors / therapeutic use
• Lupus Erythematosus, Systemic / drug therapy*
• Rituximab
• Venous Thrombosis / chemically induced*
• Young Adult